arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

SBC Medical Group Holdings Inc

SBC

$3.04 ▲ +0.05 (+1.67%) at close

4 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

SBC Medical Group Holdings Inc shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $313.1M

Dividend Yield —

Revenue Growth -15.5% ↘

Op. Margin 38.9% ↗

ROIC 14.4% ↘

FCF / Share $0.23 ↗

Trailing P/E 6.1x

Price / Book 1.3x

FCF Yield 7.4%

Debt / Equity 0.17

info Valuation on last close. End-of-day price, Aug 7, 2026.

4-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$173.61M

↓ -15.5% —

Net Income Profit after all expenses

$50.99M

↑ +9.4% —

Operating Margin Operating profit as % of sales

38.9%

↑ +13.6% 93th

FCF / Share Free cash flow per share

$0.23

↑ +21.1% —

Long-Term Debt Long-term obligations

$42.83M

↑ +549.0% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↑

Returns ↓

Financial Health →

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	-15.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-410%)	6.1% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+23%)	—	—
EPS Growth YoY (%)	4.2% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	14.3% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	9.4% Fair Fair Year-over-year change in net income	18.4% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	21.1% Good Good Year-over-year change in free cash flow	-58.3% Weak Weak Year-over-year change in free cash flow	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	38.9% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+224%)	34.2% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+185%)	36.5% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+204%)	—
Effective Tax Rate (%) (%)	37.8% Weak ↓ Weak Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	36.4% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	47.6% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	29.4% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+267%)	22.7% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+184%)	20.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+154%)	—
FCF Margin (%) (%)	13.4% Fair ↓ Fair Declining Free cash flow as a percentage of revenue Optimal: > 10%	8.8% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	21.8% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	14.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	22.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	26.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	17.7% Excellent ↓ Excellent Declining Operating profit relative to total assets Optimal: > 10%	26.4% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	27.3% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	20.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+37%)	23.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+59%)	27.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+85%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	0.17x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-75%)	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	—	—
Interest Coverage (x)	455.26x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	2484.23x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	1560.10x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-120.94M	$-118.44M	$-103.02M	$-485.56K
Debt / EBITDA (x)	0.61x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.09x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$1.69	$2.13	$2.05	—
Basic EPS, GAAP (USD)	$0.50	$0.48	$0.42	—
Free Cash Flow per Share (USD)	$0.23	$0.19	$0.45	—
Book Value per Share (USD)	$2.42	$1.90	$1.51	—
Tangible Book Value per Share (USD)	$1.80	$1.85	$1.26	—
Basic Weighted Avg Shares (shares)	103.00M	96.56M	94.19M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$170.10M	$123.26M	$73.45M	$156.18K
LT Debt (USD)	$42.83M	$6.60M	—	—
Total Equity (USD)	$248.28M	$195.11M	$142.16M	$-3.36M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$173.61M	$205.42M	$193.54M	—
Depreciation Expense (USD)	$2.68M	$3.80M	$12.25M	—
Net Income, GAAP (USD)	$50.99M	$46.61M	$39.37M	—
Operating Cash Flow (USD)	$24.67M	$20.58M	$50.67M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 17 quarters

SBC Medical Group Holdings Inc

Analytical Summary

4-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SBC with peers